-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The production process of Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd.
with 1,1′-sulfinylbis[methane] (1:1) involves several steps that are necessary to produce the final product.
The production process can be broken down into several stages, including synthesis, purification, and formulation.
The synthesis stage involves the production of the raw materials required for the production of Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd.
with 1,1′-sulfinylbis[methane] (1:1).
This involves the reaction of several chemicals in the presence of catalysts and other reagents.
The reaction conditions and the choice of reagents play a critical role in the yield and quality of the final product.
The purification stage involves the removal of impurities and other unwanted substances from the synthesized product.
This is essential to ensure that the final product meets the required purity levels.
The purification stage can involve several techniques, including crystallization, chromatography, and other techniques.
The choice of technique depends on the nature of the impurities and the desired purity level of the final product.
The formulation stage involves the production of the final product, which can involve the addition of other ingredients to enhance stability, solubility, and other properties.
The formulation stage can also involve the production of different strengths and forms of the final product, such as tablets, capsules, and suspensions.
The production process of Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd.
with 1,1′-sulfinylbis[methane] (1:1) requires strict adherence to Good Manufacturing Practices (GMP) to ensure that the final product meets the required quality standards.
This involves the use of appropriate equipment, control of environmental factors, and the use of appropriate documentation and record-keeping practices.
In conclusion, the production process of Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-, compd.
with 1,1′-sulfinylbis[methane] (1:1) involves several stages that require careful planning and execution to produce the final product.
The quality of the final product depends on strict adherence to GMP and the use of appropriate techniques and equipment throughout the production process.